Atopy and stress;Atopie et stress

Annales de Dermatologie et de Venereologie

Volumn 131, Issue 11, 2004, Pages 1008-1011

  Misery, L ^a   Roguedas, A M ^a  

^a CHU MORVAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIOLYTIC AGENT; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR;

ACCURACY; ALLERGIC ASTHMA; ARTICLE; ATOPY; CORRELATION ANALYSIS; DEPRESSION; DERMATITIS; DISEASE ASSOCIATION; FEEDBACK SYSTEM; HORMONE RELEASE; HUMAN; IMMUNOMODULATION; NEUROMODULATION; PATHOPHYSIOLOGY; PSYCHOANALYSIS; SKIN ALLERGY; SOCIAL PSYCHOLOGY; STATISTICAL SIGNIFICANCE; STRESS;

EID: 10644254817     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0151-9638(04)93820-3     Document Type: Article

References (45)

1. Thurin JM. Définition et aspects du stress. Stress, pathologies et immunité, JM Thurin, N Baumann Eds, Flammarion, Paris, 2003, pp. 15-23.
2. Besné I, Clot JP, Misery L, Breton L. Stress et dermatologie. Stress, pathologies et immunité, JM Thurin, N Baumann Eds, Flammarion, Paris, 2003, pp. 191-200.
3. Haour F, Crumeyrolle-Arias M. L'axe neuroendocrinien du stress: interface entre systèmes nerveux et immunitaire. Stress, pathologies et immunité, JM Thurin, N Baumann Eds, Flammarion, Paris, 2003, pp. 26-33.
4. Dhabhar FS, McEwen BS. Enhancing versus suppressive effects of stress hormones on skin immune function. Proc Nat Acad Sci USA 1999;96:1059-64.
5. Misery L. Are biochemical mediators the missing link between psychosomatics and dermatology? Dermatol Psychosom 2001;2:178-83.
6. Misery L. Skin, immunity and the nervous system. Br J Dermatol 1997;137:843-50.
7. Luger TA. Neuromediators - a crucial component of the skin immune system. J Dermatol Sci 2002;30:87-93.
8. Ansel JC, Kaynard AH, Armstrong CA, Olerud J, Bunnett N, Payan D. Skin-nervous system interactions. J Invest Dermatol 1996;106:198-204.
9. Dantzer R, Wollmann E. Interactions entre le système nerveux et le système immunitaire. Stress, pathologies et immunité, JM Thurin, N Baumann Eds, Flammarion, Paris, 2003, pp. 63-71.
10. Servant D. Stress et maladies. Cahiers FMC Psychiatrie 1997;201, suppl., 17-21.
11. Brown GW, Harris TO. Life events and illness. Guildford, New York, 1989.
12. Sandberg S, Paton JY, Ahola S, McCann DC, McGuinness D, Hillary CR, et al. The role of acute and chronic stress in asthma attacks in children. Lancet 2000;356:982-7.
13. Isenberg SA, Lehrer PM, Hochron S. The effects of suggestion and emotional arousal on pulmonar function in asthma: a review and a hypothesis regarding vagal mediation. Psychosom Med 1992;54:192-216.
14. Kodama A, Horikawa T, Suzuki T, Ajiki W, Takashima T, Harada S et al. Effect of stress on atopic dermatitis: investigation in patients after the great Hanshin earthquake. J Allergy Clin Immunol 1999;104:173-6.
15. Benea V, Muresian D, Manolache L, Robu E, Diaconu JD. Stress and atopic dermatitis. Dermatol Psychosom 2001;2:205-7.
16. Buske-Kirschbaum A, Geiben A, Hellhammer D. Psychobiological aspects of atopic dermatitis: an overview. Psychother Psychosom 2001;70:6-16.
17. Roguedas AM, Machet L, Fontès V, Lorette G. Dermatite atopique: quels sont les critères diagnostiques utilisés dans les articles scientifiques? Ann Dermatol Venereol, 2004;131:161-4.
18. King RM, Wilson GV. Use of a diary technique to investigate psychosomatic relations in atopic dermatitis. J Psychosom Res 1991;35:697-706.
19. Roguedas AM, Audrezet MP, Dupré D, Scotet V, Ferec C, Misery L. Significant association of polymorphism GLN27GLU of beta-2-adrenergic receptor and atopic dermatitis. J Invest Dermatol 2003;121:1570 (a).
20. Von Hertzen LC. Maternal stress and T-cell differentiation of the developing immune system: possible implications for the development of asthma and atopy. J Allergy Clin Immunol 2002;109:923-8.
21. Buske-Kirschbaum A, Gierens A, Hollig H, Hellhammer DH. Stress-induced immunomodulation is altered in patients with atopic dermatitis. J Neuroimmunol 2002;129:161-7.
22. Buske-Kirschbaum A, Hellhammer DH. Endocrine and immune responses to stress in chronic inflammatory skin disorders. Ann NY Acad Sci 2003;992:231-40.
23. Wamboldt MZ, Laudenslager M, Wamboldt FS, Kelsay K, Hewitt J. Adolescents with atopic disorders have an attenuated cortisol response to laboratory stress. J Allergy Clin Immunol 2003;111:509-14.
24. Buske-Kirschbaum A, Von Auer K, Krieger S, Weis S, Rauh W, Hellhammer D. Blunted cortisol responses to psychosocial stress in asthmatic children: a general feature of atopic disease? Psychosom Med 2003;65:806-10.
25. Slominski A, Wortsman J, Luger T, Paus R, Solomon S. Corticotropin Releasing Hormone and Proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev 2000;80:979-1020.
26. Sanders VM. The role of norepinephrine and β-2-adrenergic receptor stimulation in the modulation of TH1, TH2 and B lymphocyte function. In: Friedman H, Klein T, Madden J Eds. Drugs of abuse, immunomodulation and AIDS. New York, Plenum Press, 1998:269-78.
27. Tausk FA, Nousari H. Stress and the skin. Arch Dermatol 2001;137:78-82.
28. Saint-Mézard P, Chavagnac C, Bosset S, Ionescu M, Peyron E, Kaiserlian D, et al. Psychological stress exerts an adjuvant effect on skin dendritic cell functions in vivo. J Immunol 2003;171:4073-80.
29. Singh LK, Pang X, Alexacos N, Letourneau R, Theoharides TC. Acute immobilization stress triggers skin mast cell degranulation via corticotrophin releasing hormone, neurotensin and substance P: a link to neurogenic skin disorders. Brain Behav Immun 1999;13:225-39.
30. Katayama I, Bae SJ, Hamasaki Y, Igawa K, Miyazaki Y, Yokozeki H, et al. Stress response, tachykinin and cutaneous inflammation. J Invest Dermatol Symp Proc 2001;6:81-6.
31. Theoharides TC. What is the physiological function of mast cells. Viewpoint 2. Exp Dermatol 2003;12:891-4.
32. Altemus M, Rao B, Dhabhar FS, Ding W, Granstein RD. Stress-induced changes in skin barrier function in healthy women. J Invest Dermatol 2001;117:309-17.
33. Garg A, Chren MM, Sands LP, Matsui MS, Marenus KD, Feingold KR, et al. Psychological stress perturbs epidermal permeability barrier homeostasis. Implications forthe pathogenesis of stress-associated skin disorders. Arch Dermatol 2001;137:53-9.
34. Allain H, Lessard Y, Bentué-Ferrer D. Thérapeutiques médicamenteuses. Stress, pathologies et immunité, JM Thurin, N Baumann Eds, Flammarion, Paris, 2003, pp. 249-58.
35. Lopez G. Accompagnement et approches psychothérapeutiques du stress. Stress, pathologies et immunité, JM Thurin, N Baumann Eds, Flammarion, Paris, 2003, pp. 259-67.
36. Kemeny ME, Miller G. Effects of psychosocial interventions on the immune system. Psychoneuroimmunology. An interdisciplinary introduction. Schedlowski M, Tewes U. Eds., Kluwer Academics/Plenum Publishers, New York, 1999:373-415.
37. Légeron P. Le concept de stress. Cahiers FMC Psychiatrie 1997;201, suppl.:3-6.
38. Graziani P, Hautekeete M, Rusinek S, Servant D. Stress, anxiété et trouble de l'adaptation. Masson, Paris, 2001, 203 pp.
39. Schedlowski M, Tewes U. Psychoneuroimmunology. An interdisciplinary introduction. Kluwer Academics/Plenum Publishers, New York, 1999.
40. Al'Abadie MS, Kent GG, Gawkrodger DJ. The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions. Br J Dermatol 1994;130:199-203.
41. Misery L, Roussel H. La pelade est-elle une maladie psychosomatique? Rev Med Interne 2001;22:274-9.
42. Lahlou K, Consoli SM. Stress, personnalité et maladies cardiovasculaires. Rev Med Interne 1998;19, suppl.3:339-42.
43. Leserman J, Jackson ED, Petitto JM, Golden RN, Silva SG, Perkins DO, et al. Progression to AIDS: the effects of stress, depressive symptoms, and social support. Psychosom Med 1999;61:397-406.
44. Ruiz MR, Quinones AG, Diaz NL, Tapia FJ. Acute immobilization stress induces clinical and neuroimmunological alterations in experimental murine cutaneous leishmaniasis. Br J Dermatol 2003;149:731-8.
45. Buljevac D, Hop WC, Reedeker W, Janssens AC, van der Meche FG, van Doom PA, et al. Self reported stressful life events and exacerbations in multiple sclerosis: prospective study. BMJ 2003;327:646-9.